Literature DB >> 23181996

Guillain-Barré syndrome and catecholamine therapy. A potential risk for developing takotsubo cardiomyopathy?

Silvio Quick, Carmen Quick, Ralph Schneider, Krunoslav Sveric, Stefanie Katzke, Ruth H Strasser, Karim Ibrahim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23181996     DOI： 10.1016/j.ijcard.2012.10.083

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  5 in total

Review 1.  How to increase the utilization of donor hearts?

Authors:  Maya Guglin
Journal:  Heart Fail Rev       Date:  2015-01       Impact factor: 4.214

Review 2.  Unclassified cardiomyopathies in neuromuscular disorders.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Wien Med Wochenschr       Date:  2013-10-24

3.  Clinical features, complications, and outcomes of exogenous and endogenous catecholamine-triggered Takotsubo syndrome: A systematic review and meta-analysis of 156 published cases.

Authors:  Shams Y-Hassan; Henrik Falhammar
Journal:  Clin Cardiol       Date:  2020-03-03       Impact factor: 2.882

4.  Guillain-Barré syndrome complicated by takotsubo cardiomyopathy: an under-recognised association.

Authors:  Timothy Jones; Neelan Umaskanth; James De Boisanger; Henry Penn
Journal:  BMJ Case Rep       Date:  2020-02-13

5.  Takotsubo Cardiomyopathy as a Manifestation of Dysautonomia in Guillain-Barré Syndrome: A Case Series and Review of the Literature.

Authors:  Dyanet Puentes; Daniela Teijelo; Tamara S Stiep; Sishir Mannava; Jason Margolesky
Journal:  Cureus       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.